SomnoMed Limited - Income Statement (TTM)

SomnoMed Limited
US ˙ OTCPK ˙ AU000000SOM1

Income Statement (TTM)

SomnoMed Limited Income Statement shows changes in income and expenses over a period of time. Income Statement data includes Sales and Revenue, Gross Profit, Research and Development (R&D), Selling, General and Administrative Expense (SG&A), Operating Income, Income Tax Expense, Interest Expense, Non-Operating Income, Earnings per Share (EPS), and Shares Outstanding.

All numbers are times 1,000,000 except per share units.

2020
09-30
2020
12-31
2021
03-31
2021
06-30
2021
09-30
2021
12-31
2022
03-31
2022
06-30
2022
09-30
2022
12-31
2023
03-31
2023
06-30
2023
09-30
2023
12-31
2024
03-31
2024
06-30
2024
09-30
2024
12-31
2025
03-31
2025
06-30
Revenue 56 55 59 63 64 66 69 73 76 79 81 84 86 89 90 92 96 100 106 111
Change (%) -2.17 7.15 6.67 2.48 2.42 5.14 4.89 4.15 3.99 3.19 3.09 3.08 2.99 1.62 1.60 4.69 4.48 5.61 5.31
% of Revenue 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00
Cost Of Sales 24 23 24 25 25 25 27 28 29 30 31 32 33 34 35 37 38 40 42 45
Change (%) -2.24 3.95 3.80 0.53 0.53 6.09 5.74 3.16 3.07 2.66 2.59 3.56 3.44 3.78 3.65 4.88 4.65 5.84 5.51
% of Revenue 42.20 42.17 40.91 39.81 39.05 38.33 38.68 38.99 38.62 38.28 38.09 37.90 38.08 38.25 39.06 39.85 39.92 39.99 40.07 40.15
Gross Operating Profit 32 32 35 38 39 41 42 44 46 49 50 52 53 55 55 55 58 60 63 67
Change (%) -2.11 9.48 8.66 3.77 3.63 4.55 4.35 4.78 4.56 3.51 3.39 2.79 2.71 0.28 0.28 4.56 4.36 5.46 5.18
% of Revenue 57.80 57.83 59.09 60.19 60.95 61.67 61.32 61.01 61.38 61.72 61.91 62.10 61.92 61.75 60.94 60.15 60.08 60.01 59.93 59.85
SG&A 30 30 32 35 38 41 43 44 46 48 49 50 53 55 56 58 57 57 59 61
Change (%) -1.88 7.95 7.36 8.88 8.16 4.65 4.44 3.63 3.50 2.84 2.76 4.76 4.54 2.24 2.19 -0.83 -0.82 4.03 3.85
% of Revenue 54.18 54.34 54.75 55.11 58.55 61.83 61.54 61.28 60.97 60.68 60.48 60.29 61.27 62.19 62.57 62.94 59.62 56.60 55.75 54.98
R&D
Change (%)
% of Revenue
OpEx 57 57 60 64 67 70 73 77 79 82 85 87 91 95 97 100 101 103 107 112
Change (%) -1.50 6.23 5.87 5.09 4.84 4.77 4.55 3.58 3.45 3.05 2.96 4.36 4.17 2.72 2.65 1.32 1.31 4.48 4.27
% of Revenue 102.31 103.01 102.13 101.36 103.94 106.40 106.03 105.69 105.11 104.57 104.44 104.31 105.60 106.81 107.97 109.09 105.58 102.38 101.28 100.28
Operating Income -1 -2 -1 -1 -3 -4 -4 -4 -4 -4 -4 -4 -5 -6 -7 -8 -5 -2 -1 -0
Change (%) 27.37 -24.10 -31.75 196.36 66.26 -0.96 -0.97 -6.52 -6.98 0.17 0.17 33.90 25.32 18.85 15.86 -35.78 -55.47 -43.19 -77.02
% of Revenue -2.31 -3.01 -2.13 -1.36 -3.94 -6.40 -6.03 -5.69 -5.11 -4.57 -4.44 -4.31 -5.60 -6.81 -7.97 -9.09 -5.58 -2.38 -1.28 -0.28
Interest Expense -0 -1 -0 -0 -0 -0 -0 -0 -1 -1 -2 -3 -3 -4 -3 -2 -1 -1 -1 -0
Change (%) 5.32 -5.43 -5.74 -5.08 -5.35 -4.89 -5.14 40.31 28.73 141.19 58.54 18.80 15.83 -20.44 -25.68 -31.94 -46.92 -23.86 -31.33
% of Revenue -0.89 -0.96 -0.85 -0.75 -0.69 -0.64 -0.58 -0.52 -0.71 -0.87 -2.04 -3.14 -3.62 -4.07 -3.19 -2.33 -1.52 -0.77 -0.56 -0.36
Net Income -1 -1 -1 -1 -3 -5 -5 -4 -5 -5 -7 -8 -9 -11 -11 -12 -9 -6 -5 -3
Change (%) 10.94 -7.19 -7.75 144.15 59.04 -2.11 -2.15 8.98 8.24 26.41 20.89 16.27 13.99 7.74 7.18 -25.49 -34.22 -21.20 -26.90
% of Revenue -2.24 -2.54 -2.20 -1.90 -4.53 -7.04 -6.55 -6.11 -6.40 -6.66 -8.16 -9.57 -10.79 -11.94 -12.66 -13.36 -9.51 -5.99 -4.47 -3.10

Source: Capital IQ

Other Listings
AU:SOM A$0.74
DE:RJV €0.40
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista